Utility of Bronchoscopy and Bronchoalveolar Lavage (BAL) in the Management of Post-Stem Cell Transplant Pulmonary Complications in 101 to 1000 Days of Transplant
Rafiullah Rafiullah(University of Iowa Hospitals and Clinics), Thomas Groß(German Cancer Research Center), Yogesh Jethava(University of Iowa), Amith George Jacob(University of Iowa Hospitals and Clinics), Umar Farooq(Wake Forest University), Margarida Silverman(University of Iowa Hospitals and Clinics), Sarah L. Mott(University of Iowa), Aaron Vose(University of Iowa)
Cited by 2
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
|The Lancet Oncology|2018|2.3k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k
Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma
|New England Journal of Medicine|2023|437
Sarcopenia is an independent predictor of complications following pancreatectomy for adenocarcinoma
|Journal of Surgical Oncology|2014|274